AU2001249364A1 - Treatment of congestive heart failure with a composition comprising a diuretic agent and a vasopressin antagonist - Google Patents

Treatment of congestive heart failure with a composition comprising a diuretic agent and a vasopressin antagonist

Info

Publication number
AU2001249364A1
AU2001249364A1 AU2001249364A AU4936401A AU2001249364A1 AU 2001249364 A1 AU2001249364 A1 AU 2001249364A1 AU 2001249364 A AU2001249364 A AU 2001249364A AU 4936401 A AU4936401 A AU 4936401A AU 2001249364 A1 AU2001249364 A1 AU 2001249364A1
Authority
AU
Australia
Prior art keywords
furosemide
diuretic
urine
vasopressin antagonist
conivaptan
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001249364A
Other languages
English (en)
Inventor
Rebecca Guggemos Bakker-Arkema
Milton Lethan Pressler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Publication of AU2001249364A1 publication Critical patent/AU2001249364A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Furan Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU2001249364A 2000-05-03 2001-03-22 Treatment of congestive heart failure with a composition comprising a diuretic agent and a vasopressin antagonist Abandoned AU2001249364A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20143100P 2000-05-03 2000-05-03
US60201431 2000-05-03
PCT/US2001/009265 WO2001082920A2 (fr) 2000-05-03 2001-03-22 Traitement de l'insuffisance cardiaque congestive

Publications (1)

Publication Number Publication Date
AU2001249364A1 true AU2001249364A1 (en) 2001-11-12

Family

ID=22745788

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001249364A Abandoned AU2001249364A1 (en) 2000-05-03 2001-03-22 Treatment of congestive heart failure with a composition comprising a diuretic agent and a vasopressin antagonist

Country Status (19)

Country Link
EP (1) EP1280555B8 (fr)
JP (1) JP2003535823A (fr)
KR (1) KR20020093971A (fr)
CN (1) CN1431915A (fr)
AT (1) ATE326241T1 (fr)
AU (1) AU2001249364A1 (fr)
BR (1) BR0110566A (fr)
CA (1) CA2407929C (fr)
CZ (1) CZ20023587A3 (fr)
DE (1) DE60119723T2 (fr)
ES (1) ES2264444T3 (fr)
HU (1) HUP0300632A3 (fr)
IL (1) IL152590A0 (fr)
MX (1) MXPA02010865A (fr)
NZ (1) NZ522641A (fr)
PL (1) PL358544A1 (fr)
SK (1) SK15532002A3 (fr)
WO (1) WO2001082920A2 (fr)
ZA (1) ZA200209367B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040229781A1 (en) * 2000-05-10 2004-11-18 Marks Andrew Robert Compounds and methods for treating and preventing exercise-induced cardiac arrhythmias
WO2019141575A1 (fr) * 2018-01-16 2019-07-25 Bayer Aktiengesellschaft Assistance dans le cadre du traitement de l'insuffisance cardiaque
KR20220052561A (ko) 2020-10-21 2022-04-28 장영진 어류 가공물 및/또는 콩 가공물을 유효성분으로 포함하는 심부전의 예방 또는 치료용 약학 조성물

Also Published As

Publication number Publication date
EP1280555B8 (fr) 2006-06-28
ES2264444T3 (es) 2007-01-01
CZ20023587A3 (cs) 2003-06-18
KR20020093971A (ko) 2002-12-16
MXPA02010865A (es) 2003-03-27
ATE326241T1 (de) 2006-06-15
JP2003535823A (ja) 2003-12-02
DE60119723D1 (de) 2006-06-22
WO2001082920A3 (fr) 2002-07-18
EP1280555A2 (fr) 2003-02-05
CA2407929C (fr) 2009-05-19
HUP0300632A3 (en) 2006-02-28
CA2407929A1 (fr) 2001-11-08
BR0110566A (pt) 2003-04-01
HUP0300632A2 (hu) 2003-08-28
PL358544A1 (en) 2004-08-09
ZA200209367B (en) 2004-02-18
IL152590A0 (en) 2003-05-29
NZ522641A (en) 2003-10-31
SK15532002A3 (sk) 2003-08-05
DE60119723T2 (de) 2007-04-26
CN1431915A (zh) 2003-07-23
EP1280555B1 (fr) 2006-05-17
WO2001082920A2 (fr) 2001-11-08

Similar Documents

Publication Publication Date Title
US6645959B1 (en) Method for treating postoperative ileus
US6740648B2 (en) Treatment of pulmonary hypertension
US7192951B2 (en) Treatment of congestive heart failure
CZ246397A3 (cs) Použití karbazolových sloučenin pro výrobu léčiva pro léčení městnavého selhání srdce
US20090239844A1 (en) Ace inhibitor-vasopressin antagonist combinations
CA2407929C (fr) Traitement de l'insuffisance cardiaque congestive avec une composition comprenant un diuretique et un antagoniste de vasopressine
EP0081006B1 (fr) Compositions pharmaceutiques contenant des dérivés de la 7,8-dihydro-1-(hydroxyphényl)-2,3,4,5-tétrahydro-1H-3-benzazépine et un bloqueur beta-adrénergique
EP0278449B1 (fr) Agent modifiant la fonction rénale et diurétique et usage d'un dérivé de la benzothiazépine
CA2397244C (fr) Combinaisons d'inhibiteurs d'ace et d'antagonistes de vasopressine
AU779929B2 (en) Treatment of pulmonary hypertension